Intimation of Resignation of Chief Financial Officer(CFO) ,key Managerial Personnel under Regulation 30 of SEBI(listing Obligations and Disclosure Requirements)Regulations , 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd informed BSE that its Chief Financial Officer, Mr. Naveen Sharma, has resigned from the position of CFO and Key Managerial Personnel of the company, effective from the close of business hours on February 2, 2026. The resignation was cited as being due to personal reasons. The announcement was made under SEBI Listing Regulations. No details about a successor or replacement CFO have been disclosed in this filing. The resignation email from Mr. Sharma was also shared in the communication, requesting the company to file the requisite notice with the Registrar of Companies (ROC).
The departure of the CFO can create temporary uncertainty around financial reporting and compliance until a replacement is appointed. Shareholders should watch for any further announcement regarding the appointment of a new CFO, which will be an important signal of continuity in financial leadership.